Edwards Lifesciences Corporation (EW) — Stock Score Summary

Edwards Lifesciences Corporation (EW) has a MoatMap StockRank of 83/100 based on Quality (77/100), Value (23/100), and Momentum (67/100) factor scores. The current signal is STRONG BUY. Edwards Lifesciences is a high-quality medical device company with a strong moat in TAVR. However, it lacks a direct catalyst or alignment with our 18-month macro themes, and its valuation remains rich.

Edwards Lifesciences Corporation is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. The company's competitive moat is its proprietary technologies in heart valves and hemodynamic monitoring, strong intellectual property, and extensive clinical evidence supporting its innovative products. Edwards Lifesciences is a market leader in transcatheter aortic valve replacement (TAVR) and advanced hemodynamic monitoring, benefiting from a highly specialized and growing medical device market.

Key Financial Metrics

Price$87.54
Market Cap$49.5B
P/E (TTM)47.27
P/E (Forward)25.97
Price/Book4.89
Return on Equity10.5%
Return on Invested Capital10.9%
Debt/Equity6.81
Gross Margin77.9%
Operating Margin31.2%
Revenue Growth16.7%
Free Cash Flow$902M

Edwards Lifesciences Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Edwards Lifesciences Corporation’s (EW) StockRank?
MoatMap’s StockRank for Edwards Lifesciences Corporation (EW) is 83/100, with a Strong Buy signal. It is a composite of Quality (77), Value (23), and Momentum (67) factor ranks across MoatMap’s 19,000+ stock universe.
Does Edwards Lifesciences Corporation have an economic moat?
Edwards Lifesciences Corporation (EW) has a Quality factor score of 77/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Edwards Lifesciences Corporation a buy, hold, or sell?
MoatMap’s current signal for Edwards Lifesciences Corporation (EW) is Strong Buy, based on a StockRank of 83/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Edwards Lifesciences Corporation in?
Edwards Lifesciences Corporation (EW) operates in the Healthcare sector, specifically the Medical Devices industry (United States).